A compared with TXG: revenue, margins and what each company keeps, and the suppliers and customers both name

AAgilent Technologies, Inc.

Mkt capRevenueRevenue

TXG10x Genomics, Inc.

Mkt capRevenueRevenue

Compare

AAgilent Technologies, Inc.

TXG10x Genomics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AAgilent Technologies, Inc.

179.06▲+2.05%

Mkt cap$48.5BRevenue$1.9BQ3 FY26Revenue$6.9BFY25

TXG10x Genomics, Inc.

66.79▲+2.30%

Regular sessionNov 4 '26

Mkt cap$8.5BRevenue$151MQ2 FY26Revenue$643MFY25

Compare

Regular sessionNov 4 '26

AAgilent Technologies, Inc.

TXG10x Genomics, Inc.

179.06▲+2.05%

Price

66.79▲+2.30%

$48.5B

Mkt cap

$8.5B

Q3 FY26$1.9B

Revenue

$151MQ2 FY26

FY25$6.9B

Revenue

$643MFY25

A179.06▲+2.05%vsTXG66.79▲+2.30%Regular sessionNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

TXG: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only A 2

ALNYAlnylam Pharmaceuticalscustomer

WGSGeneDxcustomer

Shared 0

No shared counterparties.

Only TXG 4

BRKRBrukercustomer

—President and Fellows of Harvard Universityunlistedsupplier

—The Board of Trustees of the Leland Stanford Junior Universityunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Vizgen

unlistedcustomer

Price

rebased to 0%

A, solidTXG, dashed